Conclusion: After a comprehensive evaluation of molecular structure, clinical data, IGF-1 signaling, fat-loss efficacy, side-effect profiles, and long-term research utility, the answer is nuanced but clear
For all patients taking this drug: You will need to talk about the benefits and risks to you and the baby
Some studies showed prevention benefits even in the absence of metabolic changes.[ref][ref] Studies are showing positive effects on cognitive function and possibly reduced (or delayed) dementia with GLP-1s
With these insights obtained from the REDEFINE 1 trial, we plan to further explore the additional weight loss potential of CagriSema. However, CagriSemas performance was below the appoximately 25% weight loss Novo had expected, according to a report from Reuters last month
Important Safety Information What is the most important information I should know about Semaglutide